BMJ Open · 2016 · 23 citations · 22 references
MedicineCardiologyClinical CardiologyElectrophysiologyInterventional CardiologyCardiac AssessmentCardiac PacingCardiovascular MonitoringElectrocardiogram AnalysisElectrocardiogram InterpretationElectrocardiographyCardiac Implantable DevicesDisease PrognosisHis Bundle MappingImplantable Bioelectronic DevicesTreatment Prognosis Assessment
INTRODUCTION: Percutaneous aortic valve replacement (transcatheter aortic valve implantation (TAVI)) notably increases the likelihood of the appearance of a complete left bundle branch block (LBBB) by direct lesion of the LBB of His. This block can lead to high-grade atrioventricular conduction disturbances responsible for a poorer prognosis. The management of this complication remains controversial. METHOD AND ANALYSIS: The screening of LBBB after TAVI persisting for more than 24 hours will be conducted by surface ECG. Stratification will be performed by post-TAVI intracardiac electrophysiological study. Patients at high risk of conduction disturbances (≥70 ms His-ventricle interval (HV) or presence of infra-Hisian block) will be implanted with a pacemaker enabling the recording of disturbance episodes. Those at lower risk (HV <70 ms) will be implanted with a loop recorder device with remote monitoring of cardiovascular implantable electronic devices (CIEDs). Clinical, ECG and implanted device follow-up will also be performed at 3, 6 and 12 months. The primary objective is to assess the efficacy and safety of a decisional algorithm based on electrophysiological study and remote monitoring of CIEDs in the prediction of high-grade conduction disturbances in patients with LBBB after TAVI. The primary end point is to compare the incidence (rate and time to onset) of high-grade conduction disturbances in patients with LBBB after TAVI between the two groups at 12 months. Given the proportion of high-grade conduction disturbances (20-40%), a sample of 200 subjects will allow a margin of error of 6-7%. The LBBB-TAVI Study has been in an active recruiting phase since September 2015 (21 patients already included). ETHICS AND DISSEMINATION: Local ethics committee authorisation was obtained in May 2015. We will publish findings from this study in a peer-reviewed scientific journal and present results at national and international conferences. TRIAL REGISTRATION NUMBER: NCT02482844; Pre-results.
22
No Adjustments Are Needed for Multiple Comparisons
Kenneth J. Rothman · Epidemiology · 1990 · 5.8K citations
Alec Vahanian, Helmut Baumgartner, Jeroen J. Bax et al. · European Heart Journal · 2006 · 3.6K citations · Full text
Guidelines on the management of valvular heart disease (version 2012)
Alec Vahanian, Ottavio Alfieri, Felicita Andreotti et al. · European Heart Journal · 2012 · 3.6K citations · Full text
Medicine, Cardiology, Surgery +14